Table 1 Clinical data and plasma metabolic profile in patients with aortic stenosis according to the valve tissue remodelling score
All patients (n = 105)Score 2 (n = 29)Score 3 (n = 38)Score 4 (n = 38)p Wilcoxon
Age (years)70 (2)67 (2)71 (2)70 (2)0.28
Gender (male)68%54%65%82%0.05
Diabetes23%18%24%26%0.71
Hypertension61%43%76%61%0.03
CAD56%54%65%50%0.40
BMI28.3 (0.6)28.1 (1.2)27.6 (1.1)29.1 (1.1)0.84
Waist circumference (cm)100.6 (1.6)100.8 (3.1)102.2 (2.6)98.7 (2.8)0.72
Statins69%58%85%66%0.12
ACE inhibitors30%25%38%27%0.60
Bicuspid valves26%19%20%36%0.15
Smoking3.8%0%2.6%7.9%0.22
Aortic peak gradient (mm Hg)71.6 (2.1)64.5 (3.5)65.3 (3.2)83.2 (3.1)<0.001
Aortic mean gradient (mm Hg)42.6 (1.35)39.1 (2.3)37.6 (2.1)50.1 (2.0)<0.001
Aortic valve area (cm2)0.77 (0.02)0.79 (0.03)0.83 (0.03)0.70 (0.03)0.04
Creatinine (μmol/l)92.8 (2.2)87.3 (4.2)96.4 (3.7)93.6 (3.7)0.34
Glycaemia (mmol/l)5.6 (0.1)5.4 (0.2)5.6 (0.2)5.6 (0.2)0.75
LDL-C (mmol/l)2.35 (0.09)2.45 (0.18)2.15 (0.15)2.48 (0.15)0.45
HDL-C (mmol/l)1.32 (0.03)1.41 (0.06)1.26 (0.06)1.32 (0.06)0.03
Triglyceride (mmol/l)1.36 (0.06)1.28 (0.12)1.25 (0.11)1.55 (0.10)0.20
ApoB (g/l)0.70 (0.02)0.67 (0.05)0.65 (0.04)0.77 (0.04)0.07
ApoA-I (g/l)1.12 (0.02)1.11 (0.04)1.11 (0.03)1.13 (0.03)0.95
LDL peak size (Å)259.3 (0.6)259.5 (1.2)259.3 (1.0)259.1 (1.0)0.96
HDL peak size (Å)84.9 (0.6)84.8 (1.1)86.4 (1.0)83.5 (1.0)0.11
%LDL <255Å37.1 (2.1)33.1 (4.0)39.9 (3.4)38.5 (3.4)0.41
LDL-C <255Å (mmol/l)0.82 (0.05)0.79 (0.10)0.84 (0.08)0.85 (0.08)0.89
CRP (mg/l)2.21 (0.25)2.41 (0.47)2.47 (0.42)1.80 (0.42)0.48
Circulating ox-LDL (U/l)32.9 (1.5)27.3 (2.6)32.2 (2.3)38.3 (2.3)0.02
  • Results expressed as mean (SEM) unless otherwise stated.

  • ACE, angiotensin converting enzyme; Apo, apolipoprotein; BMI, body mass index; CAD, coronary artery disease; CRP, c-reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; ox-LDL, oxidized low-density lipoprotein.